Sorrento Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Sorrento Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2017 to Q2 2023.
  • Sorrento Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2023 was $10.9M, a 82.8% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $10.9M -$52.4M -82.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $12.7M -$146M -92% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $26.3M -$63.9M -70.8% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $47.2M -$75.8M -61.6% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $63.3M +$28.8M +83.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $159M -$35.7M -18.4% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $90.2M +$90.2M Dec 31, 2021 10-K 2023-03-16
Q3 2021 $123M Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $34.4M Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $194M Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-11
Q3 2019 $94K -$203K -68.4% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $316K -$7K -2.17% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $391K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $297K -$144K -32.7% Dec 31, 2018 10-Q 2019-11-12
Q3 2018 $297K Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $323K Jun 30, 2018 10-Q 2018-08-09
Q4 2017 $441K Dec 31, 2017 8-K 2019-06-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.